Mode
Text Size
Log in / Sign up
Phase 4 Completed N=34 Randomized Quadruple-blind Treatment

A Randomized Trial of Exparel vs Saline in Opioid Reduction of Pain Management Following Lumbar Spine Surgeries.

Lumbar Spine Degeneration
Source: ClinicalTrials.gov NCT04644796 ↗
Enrolled (actual)
34
Serious AEs
0.0%
Results posted
Jan 2023
Primary outcomePrimary: Postoperative Opioid Utilization — 4.82; 9.17 morphine milligram equivalents
◆ Published Evidence
Highly cited
1,284citations · ~92 / year
Practice guidelines for acute pain management in the perioperative setting: an updated report by the American Society of Anesthesiologists Task Force on Acute Pain Management.
Anesthesiology · 2012 · Open access · High-confidence link

Summary

The purpose of this study is to establish a relationship between liposomal bupivacaine surgical site injection and postop opioid utilization.

Linked Publications (5)

  • Practice guidelines for acute pain management in the perioperative setting: an updated report by the American Society of Anesthesiologists Task Force on Acute Pain Management.
    Anesthesiology · 2012 · 1,284 citations · Open access · High-confidence link
  • A novel liposomal bupivacaine formulation to produce ultralong-acting analgesia.
    Anesthesiology · 2004 · 166 citations · Open access · High-confidence link
  • The use of exparel (liposomal bupivacaine) to manage postoperative pain in unilateral total knee arthroplasty patients.
    The Journal of arthroplasty · 2015 · 136 citations · High-confidence link
  • Postoperative pain management after spinal fusion surgery: an analysis of the efficacy of continuous infusion of local anesthetics.
    Global spine journal · 2013 · 62 citations · Open access · High-confidence link
  • Postoperative Pain and Length of Stay Lowered by Use of Exparel in Immediate, Implant-Based Breast Reconstruction.
    Plastic and reconstructive surgery. Global open · 2015 · 59 citations · Open access · High-confidence link

Outcome Measures

OutcomeResultp-value
PRIMARY
Postoperative Opioid Utilization
4.82; 9.17
SECONDARY
Post Operative Pain Scores
4.80; 4.05
SECONDARY
Length of Stay
42.69; 29.51
SECONDARY
Operative Data and Complications
17; 17; 0; 0; 15; 16

Eligibility Criteria

Inclusion Criteria

  • Patients undergoing isolated lumbar spine procedures using a posterior approach.
  • Surgical spine procedures include:
  • Single-level lumbar spine surgeries with or without fusion
  • Multi-level lumbar spine surgeries with or without fusion

Exclusion Criteria

  • Procedures involving intrathecal space
  • Patients with documented allergy to local anesthetics (bupivacaine, lidocaine, procaine, benzocaine).
  • Acute lumbar trauma that requires immediate spine stabilization
  • Revision of failed back surgeries (including nonunion and malunion)
  • Revision of wound or hardware
  • Contraindication to regional anesthesia
  • Patients with chronic use of opioid medications
  • Liver dysfunction (INR > 1.5, albumin 2mg/dl)
  • Renal dysfunction (eGFR < 60ml/min/1.73m2)
  • Severe chronic obstructive pulmonary disease requiring continuous oxygen supplementation
  • Unable to give informed consent
  • Pregnancy
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04644796) and the linked publication. Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search